Ligand Pharmaceuticals M&A Summary
Ligand Pharmaceuticals has acquired 16 companies, including 7 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.
Ligand Pharmaceuticals’ largest acquisition to date was in 2020, when it acquired Pfenex for $438M. It’s largest disclosed sale occurred in 2020, when it sold Vernalis to HitGen for $25M. Ligand Pharmaceuticals has acquired in 6 different US states, and 3 countries. The Company’s most targeted sectors include life science (94%) and medical products (7%).
M&A Summary
-
M&A Total Activity17
- M&A Buy Activity16
- M&A Sell Activity1
- Total Sectors Invested 2
- Total Countries Invested 3
- M&A Buy/Sell Connections 4
Unlimited Searches
